Investments Iii L.p. ProQuest is 10% at CADENCE PHARMACEUTICALS INC (CADX). They have made 6 open-market trades across 2 companies since 2007, most recently 2014-05-29.
CIK 0001306133
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
1 open-market purchase totalling $6.7M since 2014, against 5 sales. Too few scored purchases to measure a record yet.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| AGRX | BUY | 2014-05-29 | 2014-06-02 | $6.00 | $6.7M | -16.6% | +0.2% | +0.2% |
| CADX | SELL | 2007-09-10 | 2007-09-12 | $13.53 | $157K | N/A | N/A | N/A |
| CADX | SELL | 2007-08-31 | 2007-09-04 | $14.26 | $388K | N/A | N/A | N/A |
| CADX | SELL | 2007-08-24 | 2007-08-27 | $14.21 | $200K | N/A | N/A | N/A |
| CADX | SELL | 2007-08-22 | 2007-08-24 | $14.50 | $9K | N/A | N/A | N/A |
| CADX | SELL | 2007-08-17 | 2007-08-21 | $14.86 | $113K | N/A | N/A | N/A |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.